WHO / Yutaro Setoya – COVID-19 vaccination outreach in the Ha’apai Island group of Tonga
 

COVID-19 VACCINATION IN HUMANITARIAN SETTINGS

 

Mapping the health services and supplies for COVID-19 response in Iraq

21 April 2022 – In February 2020, Iraq faced the COVID -19 pandemic, which posed a challenge to an already strained health system. To facilitate the response of humanitarian partners, the Iraq Health Cluster established the COVID -19 Task Force in April 2020, which developed the "Health Services and Supplies - COVID 19 Mapping" , an informational tool for various areas such as service delivery, facilities and resources, emergency hospital set-up, procurement and distribution of medicines, supplies, and personal protective equipment (PPE), etc., easily accessible through a consolidated platform to support communication and coordination among stakeholders.

Read more
 

RESOURCES

 

Interim statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC)

8 March 2022 – The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to review and assess the public health implications of emerging SARS-CoV-2 Variants of Concern (VOC) on the performance of COVID-19 vaccines. Since the publication of the interim statement on COVID-19 vaccines on 11 January 2022, Omicron has become the dominant VOC globally, rapidly replacing other circulating variants. This statement highlights the global epidemiological situation, challenges of updating vaccine composition and provides the current position of the TAG-CO-VAC.  

Read more>>

 

Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

13 April 2022 – The eleventh meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (2005) (IHR) regarding the coronavirus disease (COVID-19) pandemic took place on Monday 11 April 2022 from 12:00 to 16:30 Geneva time (CEST).

Read more>>

 

Survey to understand technical support required for COVID-19 response in humanitarian settings - Results Report

Global Health Cluster, April 2022

Read more>>

 

Therapeutics and COVID-19: living guideline. WHO, April 2022.

 

Read more>>

Injection safety in the context of coronavirus disease (COVID-19) vaccination: Addendum to policy brief. WHO, April 2022.

 

Read more>>

Clinical care of severe acute respiratory infections – Tool kit. WHO, April 2022.

 
 

Read more>>

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing – Interim guidance. WHO, March 2022

 

Read more>>

Summary: Consolidated financing framework for ACT-accelerator agency and in-country needs. WHO, February 2022

Read more>>

Mental Health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief. WHO, March 2022

 

Read more>>

Contact tracing and quarantine in the context of the Omicron SARS-CoV-2 variant: interim guidance. WHO, February 2022

Read more>>

COVID-19 home care bundle for health care workers. WHO, February 2022

 

Read more>>

Public health surveillance for COVID-19: interim guidance. WHO, February 2022

 

Read more>>

See more COVID-19 Resources
 

EPI-WIN: WHO Information Network for Epidemics updates

EPI-WIN seeks to give everyone access to timely, accurate, and easy-to-understand advice and information from trusted sources on public health events and outbreaks: currently the COVID-19 public health emergency.

Update 75 – COVID 19 therapeutics. WHO, March 2022.

Read more>>

Update 76 – Masks in the context of COVID-19. WHO, March 2022

Read more>>

See more EPIWIN updates
 

SAGE – Product specific documentation

See here for the Strategic Advisory Group of Experts on  immunization recommendations for use of different vaccines. 

 

SAGE April 2022 meeting highlights. WHO, April 2022

 

Read More>>>

See more SAGE guidance
 

COVID-19 VACCINE INTRODUCTION TOOLKIT

Provides guidance and tools for partners to prepare for and implement COVID-19 vaccination. Recent useful guidance includes:

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac. – WHO, March 2022. 

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm. – WHO, March 2022. 

Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19. – WHO, March 2022. 

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19  (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) – WHO, March 2022. 

COVID-19 vaccination: supply and logistics guidance. – WHO, February 2022. 

Operational guidance on establishing an ultra-cold chain system in support of the Pfizer-BioNTech COVID-19 vaccine rollout. – WHO, February 2022. 

 
COVID-19 Vaccine Introduction Toolkit
 

EVENTS

 

Webinar COVID-19 response in humanitarian settings - When there are no right answers

13 April 2022 – The Global Health Cluster and the READY Initiative co-hosted a one hour webinar on Ethics – Key questions to ask when facing dilemmas during COVID-19 response in humanitarian settings. This session provided  insights on key ethical concepts, some simple steps and key questions to ask when facing ethical dilemmas and must make difficult decisions based on competing needs and scarce resources. The tool helps link the role of frontline health care workers, health cluster partners and the health cluster as a whole to collaboratively face challenges. It also analyzed a case study from Cox's Bazar, Bangladesh.

Access the event presentation slides here >>>

Learn more
 

Keep yourself up to date

WHO RCCE Collective Service, please sign-up for updates here

WHO COVID-19 vaccine newsletter, please sign-up for updates here

WHO COVID-19 digital content newsletter, please sign-up for updates here

WHO Infodemic Management newsletter, please sign-up for updates here

COVID-19 Strategic Preparedness and Response Plan, please read here the Weekly Operational Update.

 

USEFUL LINKS 

  • GHC COVID-19          
  • WHO COVID-19     
  • IASC COVID-19  
  • OCHA COVID-19        

COVID-19 TASK TEAM

The GHC COVID-19 Task Team established a vaccine working group and is supporting two workstreams: first to monitor and track information on vaccination roll-out in humanitarian settings; and second to ensure shared learning and development of key messages.

Learn more here >>

 
Sign-up for Health Cluster Updates
 
Twitter

Follow us on Twitter 

 
 
 
 

For more about the Health Cluster: https://healthcluster.who.int/

WHO is the Cluster Lead Agency and provides secretariat support

You are receiving this email based on your engagement with the Global Health Cluster. If these emails are no longer relevant to your work, please unsubscribe below. 

Unsubscribe